Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ciclesonide

« Back to Dashboard

Summary for Generic Name: ciclesonide

Tradenames:3
Patents:12
Applicants:1
NDAs:3
Drug Master File Entries: see list7
Suppliers: see list3
Therapeutic Class:Respiratory Tract Agents

Clinical Trials for: ciclesonide

Omnaris Versus Levocetirizine Phase 4 Study
Status: Completed Condition: Allergic Rhinitis

Ciclesonide for the Treatment of Airway Hyperresponsiveness
Status: Completed Condition: Asthma

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis
Status: Completed Condition: Perennial Allergic Rhinitis

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
Status: Completed Condition: Perennial Allergic Rhinitis

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
Status: Completed Condition: Seasonal Allergic Rhinitis

Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
Status: Not yet recruiting Condition: Seasonal Allergic Rhinitis

ATEM (Alvesco Non-interventional Study)
Status: Completed Condition: Asthma; Allergy

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)
Status: Completed Condition: Rhinitis, Allergic, Perennial; Hay Fever

Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)
Status: Completed Condition: Asthma

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
Status: Completed Condition: Rhinitis, Allergic, Seasonal

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Gmbh
OMNARIS
ciclesonide
SPRAY, METERED;NASAL022004Oct 20, 2006RXYes6,939,559<disabled>Y<disabled>
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129Jan 20, 2012RXYes<disabled><disabled>
Takeda Gmbh
ALVESCO
ciclesonide
AEROSOL, METERED;INHALATION021658Jan 10, 2008RXNo6,120,752<disabled>Y<disabled>
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129Jan 20, 2012RXYes5,683,677<disabled>Y<disabled>
Takeda Gmbh
ALVESCO
ciclesonide
AEROSOL, METERED;INHALATION021658Jan 10, 2008RXYes5,683,677<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc